DEXCOM INC — Director's Dealing 2020

Sep 12, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2020-09-09

Reporting Person: DOUBLEDAY RICHARD (EVP Chief Commercial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-09-09	Common Stock	S	3297	$398.302	Disposed	48214	Direct
2020-09-09	Common Stock	S	1402	$398.302	Disposed	46812	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1530	Indirect

Footnotes

F1: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2: Included in this number are 26,348 unvested restricted stock units, 11,748 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 8,183 of which were granted on March 8, 2019 and shall vest through March 8, 2022 and 6,417 of which were granted on March 8, 2018 and shall vest through March 8, 2021.

F3: Shares are held by the Doubleday Living Trust U/A/D 5/26/2015, with respect to which the reporting person is a trustee.